Renalyse — Seed (estimated) · €1M

Renalyse, a Universitat Rovira i Virgili spin-off developing a home-monitoring device for chronic kidney disease, closed a €1M round of public and private capital led by the Fundación Botín's Mind the Gap programme (€500k), with GENESIS Ventures and the Eurostars programme participating. The company separately secured about €1M in collaborative Eurostars R&D funding and targets market launch in 2026.

LeadMind the Gap (Fundación Botín) RoundSeed (estimated) Announced10 Oct 2023 · as Renalyse (CreatSens Health) CityReus · reported Tarragona SectorHealthtech & Bio · Medtech / Diagnostics Source W B

Something wrong? Suggest a correction →